SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-063050
Filing Date
2014-02-21
Accepted
2014-02-21 17:30:34
Documents
6
Period of Report
2014-02-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d681179d8k.htm 8-K 24897
2 EX-99.1 d681179dex991.htm EX-99.1 102566
3 EX-99.2 d681179dex992.htm EX-99.2 38727
4 EX-99.3 d681179dex993.htm EX-99.3 7655
5 GRAPHIC g681179ex99_3pg001.jpg GRAPHIC 8712
6 GRAPHIC g681179small_logo.jpg GRAPHIC 3899
  Complete submission text file 0001193125-14-063050.txt   192797
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36172 | Film No.: 14634822
SIC: 2836 Biological Products, (No Diagnostic Substances)